Chemotherapy-induced resistance by ATP-binding cassette transporter genes.
about
Microparticles as Biomarkers of Blood Coagulation in CancerVisualizing functional motions of membrane transporters with molecular dynamics simulationsAdvances in the molecular detection of ABC transporters involved in multidrug resistance in cancerThe phosphodiesterase-5 inhibitor vardenafil is a potent inhibitor of ABCB1/P-glycoprotein transporterFactors determining sensitivity and resistance of tumor cells to arsenic trioxideRole of the Drug Transporter ABCC3 in Breast Cancer ChemoresistanceIdentification of novel vascular markers through gene expression profiling of tumor-derived endothelium.Role of transferrin receptor and the ABC transporters ABCB6 and ABCB7 for resistance and differentiation of tumor cells towards artesunate.Recent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugs.Potential of Central, Eastern and Western Africa Medicinal Plants for Cancer Therapy: Spotlight on Resistant Cells and Molecular Targets.Genomics of rapid adaptation to antibiotics: convergent evolution and scalable sequence amplificationCytotoxicity of four Aframomum species (A. arundinaceum, A. alboviolaceum, A. kayserianum and A. polyanthum) towards multi-factorial drug resistant cancer cell lines.A selective ATP-binding cassette subfamily G member 2 efflux inhibitor revealed via high-throughput flow cytometry.TMEM45A is essential for hypoxia-induced chemoresistance in breast and liver cancer cellsRole of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning.Fas signaling promotes chemoresistance in gastrointestinal cancer by up-regulating P-glycoprotein.Methylation of miR-129-5p CpG island modulates multi-drug resistance in gastric cancer by targeting ABC transporters.Microparticles induce multifactorial resistance through oncogenic pathways independently of cancer cell type.Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.African flora has the potential to fight multidrug resistance of cancerRedefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance.Cytotoxicity of selected Cameroonian medicinal plants and Nauclea pobeguinii towards multi-factorial drug-resistant cancer cellsPDE5 inhibitors as therapeutics for heart disease, diabetes and cancerDrug resistance: still a daunting challenge to the successful treatment of AML.Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinomaReversion of p-glycoprotein-mediated multidrug resistance in human leukemic cell line by diallyl trisulfideEvaluation of the efficacy of paclitaxel with curcumin combination in ovarian cancer cellsMicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft modelsA Gene Expression Signature Associated with Overall Survival in Patients with Hepatocellular Carcinoma Suggests a New Treatment Strategy.Anticancer property of sediment actinomycetes against MCF-7 and MDA-MB-231 cell lines.Both maltose-binding protein and ATP are required for nucleotide-binding domain closure in the intact maltose ABC transportermiR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer.Multi-functional nanocarriers to overcome tumor drug resistanceDimer opening of the nucleotide binding domains of ABC transporters after ATP hydrolysis.Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells.Evaluation of current methods used to analyze the expression profiles of ATP-binding cassette transporters yields an improved drug-discovery database.Regulation of multidrug resistance by microRNAs in anti-cancer therapyUncoupling protein 2 downregulation by hypoxia through repression of peroxisome proliferator-activated receptor γ promotes chemoresistance of non-small cell lung cancer.
P2860
Q26783691-5E741CC3-4DFE-4859-8CD0-18817C5B5D93Q26826746-436E45BE-E61A-4240-BD8B-7149B2C2AA8EQ27694658-32AB7139-1BCA-4BD8-ACBD-7D034B3EAC36Q28477938-E938C8A2-1358-4B7C-AAA2-6755CA63F834Q28483625-CA337C9C-8F64-4FA4-8810-46008E84BC3BQ28552011-6D0D9589-B157-43C6-BA89-9BB6266688A9Q30843102-09F9D657-5E49-4CBF-823F-C7C166E4E1B9Q33295383-1BD28ECB-C8B0-4547-BEAC-F15FF8910E30Q33633267-A92578E4-54DB-4C91-8497-C22B5C5C6AE7Q33753279-2116B9EC-6552-40B3-9FBF-B0F7118CDF8FQ33836661-17A6BA6B-E3E3-4688-80BA-7C41548728FEQ34256797-25B4F501-4D1C-4A20-AE62-2A5871162D51Q34393952-58A1685A-A265-486F-A4DD-984D3311CA4AQ34407155-A6CE2A42-320F-45B4-9054-493207CE8234Q34610733-1D33308B-38E0-4BA3-BB06-76CDEF7D0E59Q34786557-C0347C33-AC54-4A58-8FF0-86BC4FB177E2Q34956940-7C70B90D-F714-4DD0-B00B-53C5DB7A4EF4Q35051303-0D62A59E-4741-4745-BCCE-BC3E352710FFQ35136562-F85A6085-778F-433C-BE57-BDD51A360A6EQ35549014-71193615-45A8-441A-A460-931009861398Q35558646-316B0E3D-1FC2-4806-BADD-FDC6AD8E8267Q35765152-223A7580-32C5-44B4-ADD1-0ED279696B7AQ35827798-723E3F56-83AE-4EB8-8232-8FA3AD636A47Q35946969-6CEA06EB-D232-43EA-B2AD-A4F84373571EQ36037099-38043326-235C-47DE-9D2C-CC7E99BB7B2AQ36163183-21E2F01D-4BE2-4710-852E-60DCAA95615BQ36206234-76283A00-BADB-4B81-90FC-2E5BB76A68A7Q36341067-AEFC4725-7172-4435-BA01-CEC1AEBE9973Q36442931-B6C3F817-4AA4-4233-AF45-8623E1981556Q36502944-6D534DE9-B1AD-4355-B57A-D93831234A5BQ36719574-88F0FB05-6D7D-4342-9820-934B9808234BQ36861542-BAF4A0D2-491A-41E0-99CA-E14E189188F2Q36900550-C4075A6F-F467-4483-ACBD-4A8DB1BCE7A8Q36980340-C9EC4CA9-6F59-4FED-B0F1-457AF15573CBQ36981729-1D37AF74-0C74-4EA1-8343-04F8175F3C9BQ37119716-58295DE5-DF9D-4FE9-9A72-21BF76ADC043Q37280649-623351C1-E9D4-41D5-B0D6-C9C02C287791Q37330648-A734293A-9A8A-42A4-AA3B-B7516D606FFDQ37587311-6DC9E499-CD55-483B-BF10-254694F32DC1Q37702665-821E22D1-A461-44E9-AE57-DE464FC88D1F
P2860
Chemotherapy-induced resistance by ATP-binding cassette transporter genes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Chemotherapy-induced resistance by ATP-binding cassette transporter genes.
@en
type
label
Chemotherapy-induced resistance by ATP-binding cassette transporter genes.
@en
prefLabel
Chemotherapy-induced resistance by ATP-binding cassette transporter genes.
@en
P1476
Chemotherapy-induced resistance by ATP-binding cassette transporter genes
@en
P2093
Jean-Pierre Gillet
José Remacle
P304
P356
10.1016/J.BBCAN.2007.05.002
P407
P577
2007-06-06T00:00:00Z